Stryker bets big bucks on robotic surgery with MAKO buy
This article was originally published in Clinica
Executive Summary
Orthopedic giant Stryker has made a move into the robotic surgery segment, agreeing to buy MAKO Surgical for around $1.65bn. The deal, at $30 per share, is a massive 86% premium over MAKO’s closing share price of $16.17 on 24 September, the day before the acquisition was announced.